XNAS · IRMD
+1.80% · +$1.73 · Vol 104.0K
Market closed · last close 4:00 PM ET · price as of 16:00:05 ET
iRadimed Corporation

iRadimed Corporation

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$98.04

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is IRMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for IRMD are being assembled.
About iRadimed Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2014
Employees
166
Country
US

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$96.37
Day high
$98.40
Day low
$95.58
Previous close
$96.31
52W high
$101.25
-3.17% from high
52W low
$90.16
71% of range
Market cap
$1.2B
P/E
57.67×
EPS
$1.70
Shares out
12.8M
Volume
104K
VWAP
$97.13
Price history computed in-house
1W
-3.17%
1M
+3.22%
SMA 50 $95.00 · above
SMA 200 $95.00 · above
52W position 71%
Veridion warehouse edge

Warehouse intelligence for IRMD.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

IRMD insider activity

iRadimed Corporation

Score
Coverage building
Pressure
Net selling
Filings
136
Buys / sells
0 / 136
Net value
-$22.8M
Insiders
6
Named filers
GJ
GLENN JOHN
Insider
Leadership
SF
Scharen-Guivel Hilda Frederique
Insider
Leadership
SE
Susi Roger E.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$22.8M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-232026-06-20GLENN JOHNInsidersell$92.202,31911,937$214KSEC Form 4
2026-06-042026-06-04Scharen-Guivel Hilda FrederiqueInsidersell$95.001,2345,598$117KSEC Form 4
2026-06-042026-06-04Scharen-Guivel Hilda FrederiqueInsidersell$95.001,7666,832$168KSEC Form 4
2026-06-022026-06-01Susi Roger E.Insidersell$91.919242,162,500$85KSEC Form 4
2026-06-022026-06-01Susi Roger E.Insidersell$91.084012,163,424$37KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 131 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

IRMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IRMD in this window.
Lobbying spend

IRMD lobbying filings, year to date.

Registered lobbying filings matched to iRadimed Corporation.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IRMD in this window.
Latest news · IRMD
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for IRMD.
Options
Sovereign unlock shows live options positioning for IRMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.